The University of Liverpool has unveiled an ambitious plan to position the Liverpool City Region and the UK as a global ...

Findings Reflect Extensive Early Testing on Performance and Environmental Impact, in Collaboration with Technical Experts and Tire Industry Leaders ...

The MarketWatch News Department was not involved in the creation of this content.-- Remsima(TM) IV (intravenous) liquid formulation, the world's first liquid formulation of IV inf ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

The enhanced UPM Forte provides a surface that enables faster silicone curing and strong anchoring on release liners.

Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for ...

As drug-resistant infections continue to rise, researchers are looking for new antimicrobial strategies that are both ...

This review presents an innovative perspective on the replacement of conventional petrochemical-based surfactants with microbial biosurfactants such as rhamnolipids and sophorolipids in shampoo ...

Opinions expressed by Digital Journal contributors are their own. Amitkumar Patel has spent his career accelerating innovation adoption. His approach to reimagining patient access through precision ...

Starting in 1968, ACS Project SEED helped more than 12,000 high school students participate in summer research programs.This symposium will showcase presentations from Project SEED coordinat… Read ...

The Nanotechnology Photocatalysis Surface Coating Industry Analysis in AMEA is estimated to be valued at USD 106.4 million in 2025 and is projected to reach USD 307.1 million by 2035, registering a ...

(RTTNews) - Dogwood Therapeutics, Inc. (DWTX) said, in an all-stock transaction, it has secured a royalty free, global license to develop Serpin Pharma's intravenous formulation of SP16 to manage ...